GRFS NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Grifols SA ADR · Healthcare · Drug Manufacturers - General

Open interactive chart View report data Download investor PDF
Latest close 7.58 USD
4.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -7.6% below the Trend Line and sits at 17.4% of its 52-week range. The latest completed week returned 4.3%, after a 3.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. Options positioning is mixed with 30/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 0d.

Setup score 33 out of 100
Latest Close 7.58 USD 24 Jul 2026
1W Return 4.3% latest completed week
4W Return 3.9% short-term follow-through
12W Return -6.7% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.3% Latest completed week; four-week move 3.9%. Indicator stack 16/36 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 30/100 conviction; expected move 7.7%. News sentiment 56/100 45 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 29 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -7.6% below the Trend Line and sits at 17.4% of its 52-week range. The latest completed week returned 4.3%, after a 3.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0712-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.9% over four weeks, -6.7% over 12 weeks, and -23.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W4.3%
4W3.9%
12W-6.7%
26W-17.8%
52W-23.7%
Active trend streak0 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.71Latest activity-pressure read.
Pressure change-18.1%Four-week change in activity pressure.
Leadership-21.48Latest relative-leadership reading.
RS change27.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength62/100Blend of value, momentum, and quality. Underlying universe rank 39; rank 1 is best.
Value88/100Relative valuation strength. Underlying universe rank 13; rank 1 is best.
Quality31/100Profitability and accounting quality. Underlying universe rank 70; rank 1 is best.
Momentum13/100Medium-term price momentum. Underlying universe rank 88; rank 1 is best.
Growth27/100Revenue and earnings growth. Underlying universe rank 74; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework60/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.4x
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
10.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
37.7%
Gross profit retained from each unit of revenue.
Operating margin
16.2%
Operating profit retained from revenue.
Free-cash-flow margin
18.0%
Free cash flow generated from revenue.
Return on invested capital
6.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.0%
Latest one-year revenue growth.
EPS growth
112.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-8.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.5%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
3.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
5.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

GRFS shows mixed options pressure with a 30/100 conviction score, put-call volume ratio of 1.18, expected move of 7.7%, and Sharemaestro trend signal inactive.

Conviction30/100
Expected move7.7%
Put/call volume1.18
Pressure-6
Speculation2
Volatility77
Trend agreement74
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 45 relevant articles.

14 positive · 29 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 29 Jul 2026; event risk rises as the date approaches.
Options expected move7.7%Nearest-chain priced movement where available.
52-week drawdown-30.8%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2614 weeks finished lower.
Best week+10.0%Week of 3 Apr.
Worst week-9.1%Week of 13 Mar.
Latest week+4.3%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains6
Flat weeks2
Modest losses10
Sharp losses4
Recent vol2.6%13-week weekly-return volatility.
Base vol3.9%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis10/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.07; No reversal markers Factors48/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 57; Small Cap Core rank 9 SVQF60/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 291.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options51/100

GRFS shows mixed options pressure with a 30/100 conviction score, put-call volume ratio of 1.18, expected move of 7.7%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 7.7% Sentiment56/100

Weighted news tone is neutral across 45 relevant articles.

GRFS|Grifols SA|Price:7.580|Chg%:+0.040 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings0d

Next report is scheduled for 29 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20267.58 USD4.3%8.20 USD8.30 USD-0.71-21.485.0MOff
17 Jul 20267.27 USD0.0%8.25 USD8.32 USD-0.76-26.552.7MOff
10 Jul 20267.27 USD1.5%8.31 USD8.34 USD-0.64-30.263.7MOff
3 Jul 20267.16 USD-1.8%8.37 USD8.35 USD-0.50-30.754.0MOff
26 Jun 20267.29 USD-0.1%8.43 USD8.36 USD-0.60-29.423.2MOff
19 Jun 20267.30 USD-3.1%8.48 USD8.38 USD-0.69-33.002.3MOff
12 Jun 20267.54 USD0.0%8.52 USD8.39 USD-0.70-29.593.6MOff
5 Jun 20267.54 USD-2.7%8.56 USD8.39 USD-0.83-28.532.8MOff
29 May 20267.75 USD-1.6%8.59 USD8.40 USD-0.82-30.392.4MOff
22 May 20267.88 USD4.2%8.64 USD8.41 USD-0.77-27.683.1MOff
15 May 20267.56 USD-5.4%8.69 USD8.41 USD-0.67-30.153.3MOff
8 May 20267.99 USD-1.6%8.76 USD8.42 USD-0.54-26.752.8MOff
1 May 20268.12 USD0.5%8.81 USD8.42 USD-0.55-21.793.2MOff
24 Apr 20268.08 USD-7.7%8.87 USD8.42 USD-0.59-21.275.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.